Karen Ling has bought stock on 2 days since Aug 2021

Karen L. Ling is a corporate director and human resources executive who serves as a Director on the Board of Bausch + Lomb Corporation (NYSE/TSX: BLCO), a global eye health company.( Appointed to the Bausch + Lomb board in early 2024, she contributes significant expertise in human capital management, corporate governance, and shareholder engagement, built over more than 25 years in senior leadership roles across major healthcare and financial services organizations.( At Bausch + Lomb she is an independent director and chairs the company’s Talent and Compensation Governance Committee, focusing on executive compensation, succession, and broader workforce strategy.(

Ling previously served as Executive Vice President and Chief Human Resources Officer at American International Group (AIG) and Allergan, and held senior HR leadership positions at Merck, Forest Laboratories, Schering-Plough, and Wyeth Pharmaceuticals.( She has extensive public company board experience, including current directorships at iRhythm Technologies, Inc. and Galderma Group AG, where she chairs key compensation and human capital committees, and prior board roles at Mallinckrodt Plc and TherapeuticsMD, Inc.( Ling earned a B.A. in Economics from Yale University and a J.D. from Boston University School of Law, and began her career practicing law before moving into human resources and corporate leadership.(

Written by Perplexity from public sources.